207386-63-8

Basic information

• Product Name: N-(4-(tert-butyldimethylsilyloxy)phenyl)benzenamine
• Synonyms: N-(4-(tert-butyldimethylsilyloxy)phenyl)benzenamine
• CAS NO: 207386-63-8
• Molecular Weight: 299.488
• Mol File: 207386-63-8.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: N-(4-(tert-butyldimethylsilyloxy)phenyl)benzenamine(CAS DataBase Reference)
• NIST Chemistry Reference: N-(4-(tert-butyldimethylsilyloxy)phenyl)benzenamine(207386-63-8)
• EPA Substance Registry System: N-(4-(tert-butyldimethylsilyloxy)phenyl)benzenamine(207386-63-8)

Safety Data

• Hazardous Substances Data: 207386-63-8(Hazardous Substances Data)

Upstream product

• 18162-48-6 tert-butyldimethylsilyl chloride 
• 122-37-2 4-anilinophenol 

Downstream Products

• 1253294-00-6 2-(4-(N-phenyl-N-(4-(tert-butyldimethylsilyloxy)phenylamino))phenyl)thiophene 
• 1253294-02-8 2-(4-(N-phenyl-N-(4-(tert-butyldimethylsilyloxy)phenyl)amino)phenyl)-3,4-ethylenedioxythiophene 
• 1007561-00-3 4-bromo-N-(4-(tert-butyldimethylsilyloxy)-phenyl)-N-phenylbenzenamine 
• 1448525-91-4 N-(4-hydroxyphenyl)-3-{6-[((3S)-3-(4-morpholinylmethyl)-3,4-dihydro-2(1H)-isoquinolinyl)carbonyl]-1,3-benzodioxol-5-yl}-N-phenyl-5,6,7,8-tetrahydro-1-indolizine carboxamide hydrochloride 

Relevant articles and documents

Novel derivatives of indole and pyrrole, method for the production thereof and pharmaceutical compositions containing same

The invention relates to compounds of formula (I), wherein Ra, Rb, Rc, Rd, R3, R4, R5, A1, A2, T and W are as defined in the description. The invention also relates to drugs containing same.

INDOLE AND PYRROLE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Compounds of formula (I): wherein Ra, Rb, Rc, Rd, R3, R4, R5, A1, A2, T and W are as defined in the description. Medicinal products containing the same whic

PHOSPHATE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Compounds of formula (I): wherein X, Y, A1, A2, Ra, Rb, Rc, Rd, R3, R4, T and R5 are as defined in the description. Medicinal products containing the same which are useful in treating pathologies involving a deficit in apoptosis, such as cancer, auto-immune diseases, and diseases of the immune system.